Fear of COVID-19 and Physical Activity in Children With Asthma During the Covid Period
NCT ID: NCT05220488
Last Updated: 2022-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2022-02-03
2022-12-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Education Given to Children With Asthma
NCT06742320
The Relationship Between Kinesiophobia, Physical Activity Level and Quality of Life in Asthma Patients
NCT04181905
Comparison of Mesh Nebulizer and Compressor Nebulizer With Pulmonary Function Test in Pediatric Asthma Attacks
NCT06211998
Investigation of Physical Activity Level, Cardiorespiratory Fitness and Quality of Life in Patients With Asthma
NCT03509311
Dynamic Respiratory Muscle Strength and Endurance in Childhood Asthma
NCT06053905
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Asthma Group Inclusion Criteria:
* Having been diagnosed with asthma,
* In addition, not having any chronic disease,
* Volunteering to participate in the study,
* Not having speech and hearing problems,
* Being cooperative,
* Not having mental, neurological, orthopedic, cardiovascular or pulmonary problems that would prevent physical activity,
Asthma Group Exclusion Criteria:
* The presence of a medical indication that requires complete restriction of physical activity,
* To have had COVID-19 in the last 1 month or to be newly diagnosed with COVID-19,
* Having symptoms of COVID-19 and suspected illness,
* Existence of cooperation and communication problems.
Healthy Group Inclusion Criteria
* Not having any chronic disease for healthy individuals,
* Volunteering to participate in the study,
* Not having speech and hearing problems,
* Being cooperative,
* Not having a mental, neurological, orthopedic, cardiovascular or pulmonary problem that would prevent physical activity,
Healthy Group Exclusion Criteria
* The presence of a medical indication that requires complete restriction of physical activity,
* To have had COVID-19 in the last 1 month or to be newly diagnosed with COVID-19,
* Having symptoms of COVID-19 and suspected illness,
* Existence of cooperation and communication problems
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Asthma Group
Asthma Group
Assessment
Parameters such as physical activity and fear of covid will be evaluated in asthmatic and healthy children and adolescents.
Healthy Group
Healthy Group
Assessment
Parameters such as physical activity and fear of covid will be evaluated in asthmatic and healthy children and adolescents.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment
Parameters such as physical activity and fear of covid will be evaluated in asthmatic and healthy children and adolescents.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In addition, not having any chronic disease,
* Volunteering to participate in the study,
* Not having speech and hearing problems,
* Being cooperative,
* Not having mental, neurological, orthopedic, cardiovascular or pulmonary problems that would prevent physical activity,
* Not having any chronic disease for healthy individuals,
* Volunteering to participate in the study,
* Not having speech and hearing problems,
* Being cooperative,
* Not having a mental, neurological, orthopedic, cardiovascular or pulmonary problem that would prevent physical activity,
* Not having any chronic disease for healthy individuals,
* Volunteering to participate in the study,
* Not having speech and hearing problems,
* Being cooperative,
* Not having a mental, neurological, orthopedic, cardiovascular or pulmonary problem that would prevent physical activity,
Exclusion Criteria
* To have had COVID-19 in the last 1 month or to be newly diagnosed with COVID-19,
* Having symptoms of COVID-19 and suspected illness,
6 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bartın Unıversity
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Şeyma Nur Önal
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Şeyma Nur Önal
Role: PRINCIPAL_INVESTIGATOR
Bartın Unıversity
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bartın University
Bartın, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.
Skevaki C, Karsonova A, Karaulov A, Xie M, Renz H. Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol. 2020 Dec;146(6):1295-1301. doi: 10.1016/j.jaci.2020.09.017. Epub 2020 Sep 28.
Lovinsky-Desir S, Deshpande DR, De A, Murray L, Stingone JA, Chan A, Patel N, Rai N, DiMango E, Milner J, Kattan M. Asthma among hospitalized patients with COVID-19 and related outcomes. J Allergy Clin Immunol. 2020 Nov;146(5):1027-1034.e4. doi: 10.1016/j.jaci.2020.07.026. Epub 2020 Aug 6.
Barsoum Z. Pediatric Asthma & Coronavirus (COVID-19)-Clinical Presentation in an Asthmatic Child-Case Report. SN Compr Clin Med. 2020;2(6):700-702. doi: 10.1007/s42399-020-00310-3. Epub 2020 May 19.
Papadopoulos NG, Custovic A, Deschildre A, Mathioudakis AG, Phipatanakul W, Wong G, Xepapadaki P, Agache I, Bacharier L, Bonini M, Castro-Rodriguez JA, Chen Z, Craig T, Ducharme FM, El-Sayed ZA, Feleszko W, Fiocchi A, Garcia-Marcos L, Gern JE, Goh A, Gomez RM, Hamelmann EH, Hedlin G, Hossny EM, Jartti T, Kalayci O, Kaplan A, Konradsen J, Kuna P, Lau S, Le Souef P, Lemanske RF, Makela MJ, Morais-Almeida M, Murray C, Nagaraju K, Namazova-Baranova L, Garcia AN, Yusuf OM, Pitrez PMC, Pohunek P, Pozo Beltran CF, Roberts GC, Valiulis A, Zar HJ; Pediatric Asthma in Real Life Collaborators. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden. J Allergy Clin Immunol Pract. 2020 Sep;8(8):2592-2599.e3. doi: 10.1016/j.jaip.2020.06.001. Epub 2020 Jun 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVID-19asthmachildphysicalact
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.